IN2014DN00253A - - Google Patents
Download PDFInfo
- Publication number
- IN2014DN00253A IN2014DN00253A IN253DEN2014A IN2014DN00253A IN 2014DN00253 A IN2014DN00253 A IN 2014DN00253A IN 253DEN2014 A IN253DEN2014 A IN 253DEN2014A IN 2014DN00253 A IN2014DN00253 A IN 2014DN00253A
- Authority
- IN
- India
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
- A61K38/4893—Botulinum neurotoxin (3.4.24.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/24—Metalloendopeptidases (3.4.24)
- C12Y304/24069—Bontoxilysin (3.4.24.69), i.e. botulinum neurotoxin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161507686P | 2011-07-14 | 2011-07-14 | |
| PCT/US2012/046720 WO2013010100A1 (en) | 2011-07-14 | 2012-07-13 | Methods for treatment of incontinence associated with sexual activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN00253A true IN2014DN00253A (en) | 2015-06-05 |
Family
ID=46551933
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN253DEN2014 IN2014DN00253A (en) | 2011-07-14 | 2014-01-13 |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US9144600B2 (en) |
| EP (1) | EP2731620A1 (en) |
| JP (1) | JP6092205B2 (en) |
| KR (1) | KR20140054055A (en) |
| CN (1) | CN103813802A (en) |
| AU (1) | AU2012280947B2 (en) |
| BR (1) | BR112014000634A2 (en) |
| CA (1) | CA2841917A1 (en) |
| IN (1) | IN2014DN00253A (en) |
| RU (1) | RU2578475C2 (en) |
| WO (1) | WO2013010100A1 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050191321A1 (en) * | 2004-02-26 | 2005-09-01 | Allergan, Inc. | Methods for treating headache |
| US20100266638A1 (en) | 2004-02-26 | 2010-10-21 | Allergan, Inc. | Headache treatment method |
| SG185338A1 (en) * | 2007-10-23 | 2012-11-29 | Allergan Inc | Methods of treating urogenital-neurological disorders using modified clostridial toxins |
| AU2012280947B2 (en) * | 2011-07-14 | 2016-04-07 | Allergan, Inc. | Methods for treatment of incontinence associated with sexual activity |
| WO2015097708A1 (en) * | 2013-12-26 | 2015-07-02 | Airbus | Aircraft part with robot arm |
| US20150343036A1 (en) * | 2014-05-28 | 2015-12-03 | Allergan, Inc. | Methods for reducing the occurrence or preventing formation of bladder calculi |
| US10026824B1 (en) | 2017-01-18 | 2018-07-17 | Globalfoundries Inc. | Air-gap gate sidewall spacer and method |
| CN108573926B (en) * | 2017-03-09 | 2020-01-21 | 联华电子股份有限公司 | Semiconductor memory device and method of manufacturing the same |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9120306D0 (en) | 1991-09-24 | 1991-11-06 | Graham Herbert K | Method and compositions for the treatment of cerebral palsy |
| US5437291A (en) | 1993-08-26 | 1995-08-01 | Univ Johns Hopkins | Method for treating gastrointestinal muscle disorders and other smooth muscle dysfunction |
| US6974578B1 (en) | 1993-12-28 | 2005-12-13 | Allergan, Inc. | Method for treating secretions and glands using botulinum toxin |
| US5766605A (en) | 1994-04-15 | 1998-06-16 | Mount Sinai School Of Medicine Of The City University Of New York | Treatment of autonomic nerve dysfunction with botulinum toxin |
| EP0758900B1 (en) | 1994-05-09 | 2002-04-10 | BINDER, William J. | Botulinum toxin FOR REDUCTION OF migraine HEADACHE PAIN |
| US5670484A (en) | 1994-05-09 | 1997-09-23 | Binder; William J. | Method for treatment of skin lesions associated with cutaneous cell-proliferative disorders |
| US9066943B2 (en) * | 1997-07-15 | 2015-06-30 | The Regents Of The University Of Colorado | Use of botulinum toxin therapy for treatment of urological neurological conditions |
| DK1949909T3 (en) * | 1997-07-15 | 2014-03-24 | Univ Colorado Regents | Use of botulinum toksinterapi for the treatment of dysfunction of urge type |
| US7470431B2 (en) | 1997-07-15 | 2008-12-30 | The Regents Of The University Of Colorado | Use of neurotoxin therapy for treatment of urological-neurological disorders associated with prostate cancer |
| US6063768A (en) | 1997-09-04 | 2000-05-16 | First; Eric R. | Application of botulinum toxin to the management of neurogenic inflammatory disorders |
| US6113915A (en) | 1999-10-12 | 2000-09-05 | Allergan Sales, Inc. | Methods for treating pain |
| US6265379B1 (en) | 1999-10-13 | 2001-07-24 | Allergan Sales, Inc. | Method for treating otic disorders |
| US7838007B2 (en) * | 1999-12-07 | 2010-11-23 | Allergan, Inc. | Methods for treating mammary gland disorders |
| US7838008B2 (en) * | 1999-12-07 | 2010-11-23 | Allergan, Inc. | Methods for treating diverse cancers |
| US6139845A (en) | 1999-12-07 | 2000-10-31 | Allergan Sales, Inc. | Method for treating cancer with a neurotoxin |
| US6143306A (en) | 2000-01-11 | 2000-11-07 | Allergan Sales, Inc. | Methods for treating pancreatic disorders |
| US6358513B1 (en) | 2000-02-15 | 2002-03-19 | Allergan Sales, Inc. | Method for treating Hashimoto's thyroiditis |
| US6328977B1 (en) | 2000-02-22 | 2001-12-11 | Allergan Sales, Inc. | Method for treating hyperparathyroidism |
| US6464986B1 (en) | 2000-04-14 | 2002-10-15 | Allegan Sales, Inc. | Method for treating pain by peripheral administration of a neurotoxin |
| US6299893B1 (en) | 2000-04-17 | 2001-10-09 | Marvin Schwartz | Method to reduce hair loss and stimulate hair regrowth |
| US6306423B1 (en) | 2000-06-02 | 2001-10-23 | Allergan Sales, Inc. | Neurotoxin implant |
| US6306403B1 (en) | 2000-06-14 | 2001-10-23 | Allergan Sales, Inc. | Method for treating parkinson's disease with a botulinum toxin |
| US6423319B1 (en) | 2000-10-04 | 2002-07-23 | Allergan Sales, Inc. | Methods for treating muscle injuries |
| EP1434530A2 (en) * | 2001-10-12 | 2004-07-07 | AMS Research Corporation | Surgical instrument and method |
| US20040266776A1 (en) * | 2003-06-25 | 2004-12-30 | Gil Daniel W. | Methods of preventing and reducing the severity of stress-associated conditions |
| US20040067235A1 (en) * | 2002-07-29 | 2004-04-08 | Rajiv Doshi | Methods for the use of neurotoxin in the treatment of urologic disorders |
| US8609112B2 (en) * | 2003-10-29 | 2013-12-17 | Allergan, Inc. | Botulinum toxin treatments of depression |
| US8609113B2 (en) * | 2003-10-29 | 2013-12-17 | Allergan, Inc. | Botulinum toxin treatments of depression |
| US20050191321A1 (en) * | 2004-02-26 | 2005-09-01 | Allergan, Inc. | Methods for treating headache |
| US20100266638A1 (en) * | 2004-02-26 | 2010-10-21 | Allergan, Inc. | Headache treatment method |
| GB0426394D0 (en) | 2004-12-01 | 2005-01-05 | Health Prot Agency | Fusion proteins |
| US7659092B2 (en) | 2004-12-01 | 2010-02-09 | Syntaxin, Ltd. | Fusion proteins |
| WO2008030638A2 (en) * | 2006-05-16 | 2008-03-13 | Mayo Foundation For Medical Education And Research | Use of dmso and botulinum toxin therapy for urinary incontinence and related disorders |
| GB0610867D0 (en) | 2006-06-01 | 2006-07-12 | Syntaxin Ltd | Treatment of pain |
| ES2441961T3 (en) * | 2007-02-15 | 2014-02-07 | Allergan, Inc. | Botulinum toxin compositions and methods |
| SG185338A1 (en) * | 2007-10-23 | 2012-11-29 | Allergan Inc | Methods of treating urogenital-neurological disorders using modified clostridial toxins |
| US8470337B2 (en) * | 2008-03-13 | 2013-06-25 | Allergan, Inc. | Therapeutic treatments using botulinum neurotoxin |
| US20100303756A1 (en) * | 2009-05-29 | 2010-12-02 | Allergan, Inc. | Methods of Treating Urogenital-Neurological Disorders Using Interleukin Retargeted Endopepidases |
| US8940308B2 (en) * | 2010-03-30 | 2015-01-27 | Allergan, Inc. | Methods for treating depression |
| AU2012280947B2 (en) * | 2011-07-14 | 2016-04-07 | Allergan, Inc. | Methods for treatment of incontinence associated with sexual activity |
-
2012
- 2012-07-13 AU AU2012280947A patent/AU2012280947B2/en not_active Ceased
- 2012-07-13 EP EP12738350.3A patent/EP2731620A1/en not_active Ceased
- 2012-07-13 KR KR1020147003752A patent/KR20140054055A/en not_active Application Discontinuation
- 2012-07-13 RU RU2014103542/15A patent/RU2578475C2/en not_active IP Right Cessation
- 2012-07-13 JP JP2014520379A patent/JP6092205B2/en not_active Expired - Fee Related
- 2012-07-13 CN CN201280042815.5A patent/CN103813802A/en active Pending
- 2012-07-13 US US13/548,623 patent/US9144600B2/en active Active
- 2012-07-13 BR BR112014000634A patent/BR112014000634A2/en not_active IP Right Cessation
- 2012-07-13 WO PCT/US2012/046720 patent/WO2013010100A1/en active Application Filing
- 2012-07-13 CA CA2841917A patent/CA2841917A1/en not_active Abandoned
-
2014
- 2014-01-13 IN IN253DEN2014 patent/IN2014DN00253A/en unknown
-
2015
- 2015-09-25 US US14/865,547 patent/US9480732B2/en active Active
-
2016
- 2016-10-28 US US15/337,096 patent/US10034923B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2012280947B2 (en) | 2016-04-07 |
| WO2013010100A1 (en) | 2013-01-17 |
| AU2012280947A1 (en) | 2014-01-30 |
| EP2731620A1 (en) | 2014-05-21 |
| US10034923B2 (en) | 2018-07-31 |
| RU2578475C2 (en) | 2016-03-27 |
| JP6092205B2 (en) | 2017-03-08 |
| KR20140054055A (en) | 2014-05-08 |
| RU2014103542A (en) | 2015-08-20 |
| US20160008441A1 (en) | 2016-01-14 |
| BR112014000634A2 (en) | 2017-02-14 |
| US9480732B2 (en) | 2016-11-01 |
| US9144600B2 (en) | 2015-09-29 |
| US20170042984A1 (en) | 2017-02-16 |
| CN103813802A (en) | 2014-05-21 |
| JP2014520861A (en) | 2014-08-25 |
| US20130034587A1 (en) | 2013-02-07 |
| CA2841917A1 (en) | 2013-01-17 |